Evidence map›Paper›PMID 36249227›Full record

ArticleFrontiers in public health2022

COVID-19-related stigma and its relationship with mental wellbeing: A cross-sectional analysis of a cohort study in Japan.

Emiko Sawaguchi, Sho Nakamura, Kaname Watanabe, Kanami Tsuno, Hiromi Ikegami, Naoko Shinmura, Yoshinobu Saito, Hiroto Narimatsu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emiko SawaguchiGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
Sho NakamuraGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
Kaname WatanabeCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Kanami TsunoGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
Hiromi IkegamiCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Naoko ShinmuraCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Yoshinobu SaitoCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Hiroto NarimatsuGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
Kanagawa Cancer CenterKanagawa Prefectural Hospital Organization · JPKanagawa University of Human Services · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Social stigma related to coronavirus disease (COVID-19), i. e., COVID-19 stigma, forms a burden on people socially, economically, and mentally. This study assessed COVID-19 stigma using a scale to identify a population likely to exhibit higher prejudice against COVID-19 itself as well as those infected with COVID-19. Methods: We adapted and modified the Cancer Stigma Scale to assess COVID-19 stigma and used it as the baseline survey of a cohort study in Japan. The questionnaire was disseminated to 1,573 participants (51.7% men) between December 2020 and March 2021. The questionnaire items included the infection status of individuals close to the respondent and their preventive behaviors related to COVID-19, quality of life (QOL; using the EuroQoL 5-Dimension 5-Level [EQ-5D-5L]), and psychological distress (using the 6-item Kessler Psychological Distress Scale [K6]). Exploratory and confirmatory factor analyses were performed to validate the COVID-19 stigma scale, and we further used the structural equation modeling (SEM) to assess the relationship with QOL and psychological distress. Results: COVID-19 stigma was calculated for the 257 (16.3%) participants who responded to the questionnaire. The mean age (standard deviation) was 54.5 (14.4) years, and 50.2% were men. Factor analysis revealed a five-factor model: Awkwardness (feeling uncomfortable being with a person infected before), Severity (fear of not being able to return to normal after infection), Avoidance (attitude of avoiding infected persons), Policy Opposition (expecting more public funding investment), and Personal Responsibility (believing that infected persons themselves are responsible for their infection). Participants > 70 years had the highest scores among other age groups considering all factors except for Policy Opposition. Standardized coefficients in SEM for COVID-19 stigma (latent variable) was highest for Severity (beta = 0.86). Regression coefficients of COVID-19 stigma on K6 and QOL were 0.21 (95% confidence interval [CI] 0.074-0.342) and -0.159 (95% CI -0.295-0.022), respectively. Conclusion: People aged ≥ 70 years are more likely to exhibit COVID-19 stigma. Additionally, the results indicate that COVID-19 stigma impacts QOL and psychological distress.

Indexed as

COVID-19Social StigmaCohort StudiesCross-Sectional StudiesFemaleHumansJapanMaleMiddle AgedQuality of LifeCOVID-19emerging communicable diseaseshealth communicationpopulation healthquality of liferisk factorssocial stigmavulnerable populations

Identifiers

PMID36249227
PMCPMC9558281
OpenAlexW4297997414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.